Satreda is a dynamic startup dedicated to advancing lipid nanoparticle (LNP) technology for gene drug research, development, and production. We are currently working to develop innovative LNP solutions in two key areas:
1. Standardized LNP Carrier Tools:
We aim to create ready-to-use, standardized LNP carriers designed for efficient RNA and DNA delivery, from in vitro cell transfection to in vivo animal studies. Our goal is to develop user-friendly technology that allows researchers to encapsulate trace amounts of RNA and DNA with ease, supporting a wide range of cell lines. We’re working towards a versatile system compatible with various RNA types and plasmid DNA (pDNA).
2. Proprietary Custom LNP Platform:
Satreda is building a proprietary LNP platform based on a Quality by Design (QbD) framework to offer customized formulations tailored to specific needs. Our vision is to develop solutions optimized for targeted delivery to organs such as the liver, lungs, and skin, with a focus on efficiency, scalability, and safety. This platform will be supported by independent intellectual property to ensure both innovation and reliability.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Adolph Bergs Vei 30d, Bergen,vestland 5089,norway
- Industry
- Nanotechnology Research
- NAICS
-
Research and Development in Nanotechnology
- Website
- http://www.satreda.com
- HQ
- Bergen, Vestland
Satreda As Questions
Satreda As's website is http://www.satreda.com
Satreda As's LinkedIn profile is https://no.linkedin.com/company/satreda
Satreda As has
2 employees.
View email and phone details for 2
employees at Satreda As.
Satreda As's industry is
Nanotechnology Research
Satreda As's top competitors are
Nextpharma,
Celid Biotechnologies Inc.,
Navera Therapeutics,
Vitusapotek,
Pharma Norge As,
Lenvayo,
Farmasøyter Uten Grenser Norge,
Strimo As,
Novopyxis,
Navera.
Satreda As's categories are Nanotechnology Research
Satreda As's founding year is 2024
